If we were go back 2 years say or 4 years and replace NP with any other CEO, I 100% believe mono would not have happened. NP has tenacity of no other, he has almost willed mono into existence, even against the inventor who didn’t think it possible and with 30-40% responders rate with mono in phase 2. Same thing with financing, NP has worked tirelessly to raise funds. He will knock on as many doors at it takes. Why no parter years ago? Because BP didn’t believe mono was possible, no one outside Cydy did. Why should they? It has never been done. So NP had to fight for cash, sometime one month ahead, while not giving leronlimab away for free and while not completely destroying the sp. Very few other CEOs would have. Sure they could have did a RS last year, raised $50M, which after the RS would have wiped out the then current shareholders and started fresh. I’ve seen it done many times. I trade a lot of preclinical Nasdaq biotech. Many go like this. Raise funds, rs, raise funds rs, raise funds, rs. They have to keep the sp above $1, fundraising drops it below, and they have to rs to bring it back up, allowing shorts and capitalists to bring it down again. Then they need more funds, so it cycles. Most other CEOs would have, taking the easy way out, but destroying they old shareholders. NP said yesterday, there will be no RS.
Will the board replace NP? No, never before drug approval; they know this. They overlook his flaws, and he has some indeed, but they know this man is going to carry them to the promise land as long as he has life in him. He reminds me of that song, “I get knocked down. I get up again. You’re never going to keep me down.”
Will the board replace NP? No, never before drug approval; they know this. They overlook his flaws, and he has some indeed, but they know this man is going to carry them to the promise land as long as he has life in him. He reminds me of that song, “I get knocked down. I get up again. You’re never going to keep me down.”
2
